Cornelia Bargmann

Cornelia Bargmann, born in 1961, is a distinguished American neurobiologist renowned for her pioneering research on the genetic and neural circuit mechanisms that govern behavior. Her groundbreaking work primarily focuses on the model organism C. elegans, where she has made significant contributions to understanding the mechanisms of olfaction.

Throughout her illustrious career, Bargmann has been recognized for her exceptional contributions to science. She was elected to the National Academy of Sciences, highlighting her influence and expertise in the field. From 1995 to 2016, she served as a Howard Hughes Medical Institute investigator at both the University of California, San Francisco, and Rockefeller University.

In 2016, she took on the role of Head of Science at the Chan Zuckerberg Initiative, where she continued to drive scientific innovation until 2022. Her accolades include the prestigious Kavli Prize, awarded in 2012, which came with a monetary award of one million dollars, and the Breakthrough Prize in Life Sciences in 2013, which recognized her work with a remarkable three million dollars.